Mesirow Financial Investment Management - Fixed Income’s Collegium Pharmaceutical COLL Stock Holding History

Mesirow Financial Investment Management - Fixed Income’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-319,395	Closed	-$5.66M	–	34
2022 Q2	$5.66M	Buy	+319,395	New	+$5.37M	0.72%	73
2021 Q3	–	Sell	-416,244	Closed	-$9.84M	–	137
2021 Q2	$9.84M	Sell	416,244 -9,875	-2%	-$228K	1.1%	30
2021 Q1	$10.1M	Sell	426,119 -3,750	-0.9%	-$89.1K	1.17%	21
2020 Q4	$8.61M	Buy	429,869 +126,184	+42%	+$2.46M	1.15%	25
2020 Q3	$6.32M	Buy	303,685 +9,075	+3%	+$164K	1.07%	30
2020 Q2	$5.16M	Sell	294,610 -4,730	-2%	-$92.6K	0.94%	49
2020 Q1	$4.89M	Buy	+299,340	New	+$6.18M	1.16%	42

Other funds holding COLL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Mesirow Financial Investment Management - Fixed Income's COLL Position: Q3 2022 in Review

Mesirow Financial Investment Management - Fixed Income sold out of Collegium Pharmaceutical (COLL) in Q3 2022, closing a stake of 319,395 shares — an estimated $5.66M sold.

Mesirow Financial Investment Management - Fixed Income first reported a position in COLL in Q1 2020 and held it in 7 quarters. The position peaked at $10.1M in Q1 2021. 168 funds tracked by Wall St. Rank hold COLL as of Q3 2022.

Mesirow Financial Investment Management - Fixed Income reported no remaining Collegium Pharmaceutical position as of Q3 2022 after selling out during the quarter.
Mesirow Financial Investment Management - Fixed Income sold 319,395 Collegium Pharmaceutical shares in Q3 2022, an estimated $5.66M.
Mesirow Financial Investment Management - Fixed Income first reported a position in Collegium Pharmaceutical in Q1 2020 and held it in 7 quarters.
Mesirow Financial Investment Management - Fixed Income's Collegium Pharmaceutical position peaked at $10.1M in Q1 2021.
168 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2022.

Based on Mesirow Financial Investment Management - Fixed Income's 13F filing for Q3 2022, filed 8 Nov 2022.